Characterizing Carbapenemase Genes in Carbapenem-Resistant Enterobacter cloacae: Insights from Guangdong Province

Study Background and Research Question

Antimicrobial resistance, particularly among Gram-negative pathogens, is an escalating global crisis, compounded by the COVID-19 pandemic's impact on antibiotic usage and healthcare infrastructure. Carbapenem-resistant Enterobacter cloacae (CREC) represents a mounting challenge in tertiary hospitals, with limited therapeutic options and rising detection rates in diverse clinical settings. The reference study addresses a critical knowledge gap: how are carbapenemase-encoding genes (CEGs) distributed, transferred, and epidemiologically manifested in CREC strains during and after the COVID-19 pandemic in a densely populated region?

Key Innovation from the Reference Study

The core innovation of the study by Chen et al. (2025) is its systematic dissection of CEG localization (plasmid versus chromosomal), transfer dynamics, and the prevalence of specific genetic elements mediating resistance. While previous surveillance studies have largely focused on prevalence or phenotypic resistance, this work delineates the molecular underpinnings of resistance spread—quantifying the success rates of gene transfer and mapping the diversity of mobile genetic elements. Notably, the research finds that the blaNDM-1 gene is predominantly plasmid-borne, facilitating high rates of horizontal transfer, and highlights the complex interplay of multiple mobile elements in driving epidemiological patterns.

Methods and Experimental Design Insights

The study analyzed 54 CREC isolates obtained from eight teaching hospitals in Guangdong Province between December 2022 and June 2024. The methodology integrated molecular, microbiological, and bioinformatic approaches:

• Plasmid elimination and PCR: Variable temperature SDS-based approaches were combined with polymerase chain reaction to identify the presence and localization of CEGs.
• Antibiotic susceptibility testing: Broth microdilution was used to compare resistance profiles between CEG-positive and -negative strains.
• Conjugation experiments: Plasmid transferability was directly quantified via mating assays and PCR verification.
• Mobile element identification: Six types of mobile genetic elements were mapped, with prevalence and co-occurrence patterns documented.
• Genotyping: ERIC-PCR and NTSYS software enabled high-resolution clustering of isolates into 17 genotypes, supporting epidemiological tracking.

By combining these techniques, the study provides a robust, multidimensional view of resistance gene ecology within a defined healthcare network.

Core Findings and Why They Matter

The reference study delivers several important findings relevant to antibiotic resistance research and infection control:

• High prevalence and localization of CEGs: 85.19% of isolates harbored carbapenemase genes, with the majority possessing blaNDM-1 either on both plasmids and chromosomes (33.33%) or exclusively on plasmids (46.30%).
• Transfer efficiency: Plasmid conjugation experiments demonstrated a 95.65% success rate for CEG transfer, with blaNDM-1 at 95.45% and blaIMP at 100%. This underscores the potential for rapid horizontal dissemination within and between healthcare facilities.
• Mobile genetic elements: Six distinct elements were identified, with ISEcp1 present in 87.04% of isolates. CRECs with four types of mobile elements were most prevalent, suggesting a genetic environment primed for recombination and resistance amplification.
• Antibiotic resistance spectrum: CEG-positive strains exhibited markedly higher resistance to imipenem, cefepime, gentamicin, ceftazidime/avibactam, ciprofloxacin, and levofloxacin compared to CEG-negative counterparts (P<0.05).
• Epidemiological correlations: Higher detection rates were observed in male and elderly patients, respiratory medicine departments, and sputum samples, indicating possible demographic and clinical risk factors.
• Genotypic diversity: The 54 isolates were grouped into 17 genotypes, with types E and G most prevalent, and instances of 100% genetic similarity among certain strains, highlighting possible intra-hospital transmission clusters.

These findings collectively highlight an urgent need for enhanced infection control and molecular surveillance in regions experiencing high CREC prevalence, as the genetic infrastructure for resistance propagation is both robust and adaptable.

Comparison with Existing Internal Articles

Several internal resources provide mechanistic and protocol-level insights into combating multidrug-resistant Gram-negative infections, complementing the reference study's epidemiological focus. For example, "Polymyxin B (Sulfate): Mechanisms, Benchmarks, and Research" details the molecular action of Polymyxin B sulfate as a cationic detergent antibiotic disrupting bacterial membranes, with particular effectiveness against Pseudomonas aeruginosa and other multidrug-resistant pathogens. Likewise, "Polymyxin B (Sulfate): Advanced Protocols for Sepsis and Immune Assays" discusses how this agent is integrated into sepsis models and dendritic cell maturation assays, supporting research into both direct bactericidal activity and immunomodulation.

While Chen et al. focus on transmission genetics and hospital epidemiology, these internal articles offer practical guidance for in vitro and in vivo experimental approaches, including the use of Polymyxin B sulfate in workflows for Gram-negative bacterial infection research. The synergy of molecular epidemiology with targeted laboratory tools can empower more rational development and testing of countermeasures.

Protocol Parameters

• Broth microdilution: Standardized for resistance profiling; follow CLSI guidelines for clinical isolates.
• Plasmid elimination: SDS-based treatment at variable temperatures (e.g., 37°C vs. 42°C) to distinguish chromosomal from plasmid-borne genes.
• Conjugation assays: Use filter-mating protocols, verifying successful transfer via PCR.
• ERIC-PCR genotyping: Amplification with ERIC primers, clustering using NTSYS for tracking transmission chains.
• Mobile element mapping: Multiplex PCR or sequencing for specific insertion sequences (e.g., ISEcp1).

Limitations and Transferability

The study’s scope is geographically circumscribed to eight teaching hospitals in Guangdong and temporally focused on the COVID-19 pandemic period (2022–2024). While the large sample size and integration of molecular and phenotypic assays strengthen its conclusions, transferability to other regions or post-pandemic contexts may require further validation. Additionally, the lack of detailed clinical outcome data limits inference about patient-level impacts. However, the high transferability of CEGs and the prominence of mobile genetic elements observed suggest that similar patterns may emerge in other settings with high antibiotic selection pressure.

Research Support Resources

For researchers replicating or extending these workflows, use of validated reagents is critical. Polymyxin B (sulfate) (SKU C3090) is widely used as a reference antibiotic for bloodstream and urinary tract infection models, including resistance profiling and dendritic cell maturation assays. APExBIO provides high-quality formulations suitable for in vitro and in vivo studies, supporting reproducibility in Gram-negative bacterial infection research. Consult product documentation for storage and handling guidance, and integrate with established protocols as described above.